vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与SHORE BANCSHARES INC（SHBI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是SHORE BANCSHARES INC的1.3倍（$75.5M vs $59.1M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 11.8%），SHORE BANCSHARES INC自由现金流更多（$59.2M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 11.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Shore Bancshares Inc.是总部位于美国马里兰州的区域性银行控股企业，主要为运营区域内的个人客户、小微企业及中型企业提供存款、各类贷款、财富管理方案等零售及商业金融服务。
PBYI vs SHBI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$59.1M
营收增速更快
PBYI
高出15.9%
11.8%
自由现金流更多
SHBI
多$44.8M
$14.4M
两年增速更快
PBYI
近两年复合增速
11.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $59.1M |
| 净利润 | — | — |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 35.2% |
| 净利率 | — | — |
| 营收同比 | 27.7% | 11.8% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.26 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISHBI
| Q4 25 | $75.5M | $59.1M | ||
| Q3 25 | $54.5M | $56.4M | ||
| Q2 25 | $52.4M | $56.6M | ||
| Q1 25 | $46.0M | $53.0M | ||
| Q4 24 | $59.1M | $52.9M | ||
| Q3 24 | $80.5M | $50.5M | ||
| Q2 24 | $47.1M | $50.6M | ||
| Q1 24 | $43.8M | $47.7M |
净利润PBYISHBI
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $14.3M | ||
| Q2 25 | $5.9M | $15.5M | ||
| Q1 25 | $3.0M | $13.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $11.2M | ||
| Q2 24 | $-4.5M | $11.2M | ||
| Q1 24 | $-4.8M | $8.2M |
毛利率PBYISHBI
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYISHBI
| Q4 25 | 22.7% | 35.2% | ||
| Q3 25 | 17.6% | 33.7% | ||
| Q2 25 | 12.7% | 36.5% | ||
| Q1 25 | 8.7% | 34.4% | ||
| Q4 24 | 22.6% | 34.3% | ||
| Q3 24 | 27.4% | 29.6% | ||
| Q2 24 | -4.6% | 29.7% | ||
| Q1 24 | -5.3% | 22.2% |
净利率PBYISHBI
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | 25.5% | ||
| Q2 25 | 11.2% | 27.4% | ||
| Q1 25 | 6.5% | 26.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | 22.1% | ||
| Q2 24 | -9.6% | 22.2% | ||
| Q1 24 | -11.0% | 17.2% |
每股收益（稀释后）PBYISHBI
| Q4 25 | $0.26 | $0.48 | ||
| Q3 25 | $0.17 | $0.43 | ||
| Q2 25 | $0.12 | $0.46 | ||
| Q1 25 | $0.06 | $0.41 | ||
| Q4 24 | $0.40 | $0.39 | ||
| Q3 24 | $0.41 | $0.34 | ||
| Q2 24 | $-0.09 | $0.34 | ||
| Q1 24 | $-0.10 | $0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $355.6M |
| 总债务越低越好 | $22.7M | $89.1M |
| 股东权益账面价值 | $130.3M | $589.9M |
| 总资产 | $216.3M | $6.3B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资PBYISHBI
| Q4 25 | $97.5M | $355.6M | ||
| Q3 25 | $94.4M | $416.5M | ||
| Q2 25 | $96.0M | $185.0M | ||
| Q1 25 | $93.2M | $389.0M | ||
| Q4 24 | $101.0M | $459.9M | ||
| Q3 24 | $96.7M | $183.6M | ||
| Q2 24 | $96.8M | $138.9M | ||
| Q1 24 | $107.2M | $114.6M |
总债务PBYISHBI
| Q4 25 | $22.7M | $89.1M | ||
| Q3 25 | $34.0M | $74.5M | ||
| Q2 25 | $45.3M | $74.2M | ||
| Q1 25 | $56.7M | $74.0M | ||
| Q4 24 | $68.0M | $73.7M | ||
| Q3 24 | $79.3M | $123.5M | ||
| Q2 24 | $90.7M | $122.8M | ||
| Q1 24 | $102.0M | $72.6M |
股东权益PBYISHBI
| Q4 25 | $130.3M | $589.9M | ||
| Q3 25 | $115.3M | $577.2M | ||
| Q2 25 | $104.7M | $565.2M | ||
| Q1 25 | $97.1M | $552.5M | ||
| Q4 24 | $92.1M | $541.1M | ||
| Q3 24 | $71.1M | $533.3M | ||
| Q2 24 | $48.5M | $522.8M | ||
| Q1 24 | $51.0M | $515.2M |
总资产PBYISHBI
| Q4 25 | $216.3M | $6.3B | ||
| Q3 25 | $202.9M | $6.3B | ||
| Q2 25 | $194.9M | $6.0B | ||
| Q1 25 | $196.2M | $6.2B | ||
| Q4 24 | $213.3M | $6.2B | ||
| Q3 24 | $220.7M | $5.9B | ||
| Q2 24 | $205.0M | $5.9B | ||
| Q1 24 | $214.1M | $5.8B |
负债/权益比PBYISHBI
| Q4 25 | 0.17× | 0.15× | ||
| Q3 25 | 0.30× | 0.13× | ||
| Q2 25 | 0.43× | 0.13× | ||
| Q1 25 | 0.58× | 0.13× | ||
| Q4 24 | 0.74× | 0.14× | ||
| Q3 24 | 1.12× | 0.23× | ||
| Q2 24 | 1.87× | 0.23× | ||
| Q1 24 | 2.00× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $62.4M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $59.2M |
| 自由现金流率自由现金流/营收 | 19.1% | 100.2% |
| 资本支出强度资本支出/营收 | 0.0% | 5.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $110.6M |
8季度趋势，按日历期对齐
经营现金流PBYISHBI
| Q4 25 | $14.4M | $62.4M | ||
| Q3 25 | $9.7M | $42.5M | ||
| Q2 25 | $14.1M | $-8.3M | ||
| Q1 25 | $3.6M | $19.8M | ||
| Q4 24 | $15.6M | $46.9M | ||
| Q3 24 | $11.0M | $9.1M | ||
| Q2 24 | $1.0M | $3.0M | ||
| Q1 24 | $11.2M | $2.4M |
自由现金流PBYISHBI
| Q4 25 | $14.4M | $59.2M | ||
| Q3 25 | $9.7M | $41.9M | ||
| Q2 25 | $14.1M | $-9.2M | ||
| Q1 25 | $3.6M | $18.8M | ||
| Q4 24 | $15.6M | $41.7M | ||
| Q3 24 | $11.0M | $8.4M | ||
| Q2 24 | $1.0M | $1.4M | ||
| Q1 24 | — | $614.0K |
自由现金流率PBYISHBI
| Q4 25 | 19.1% | 100.2% | ||
| Q3 25 | 17.7% | 74.3% | ||
| Q2 25 | 26.8% | -16.3% | ||
| Q1 25 | 7.7% | 35.4% | ||
| Q4 24 | 26.4% | 78.8% | ||
| Q3 24 | 13.7% | 16.7% | ||
| Q2 24 | 2.1% | 2.9% | ||
| Q1 24 | — | 1.3% |
资本支出强度PBYISHBI
| Q4 25 | 0.0% | 5.4% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | 0.0% | 1.6% | ||
| Q1 25 | 0.1% | 1.9% | ||
| Q4 24 | 0.0% | 9.9% | ||
| Q3 24 | 0.0% | 1.2% | ||
| Q2 24 | 0.0% | 3.1% | ||
| Q1 24 | 0.0% | 3.7% |
现金转化率PBYISHBI
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 2.96× | ||
| Q2 25 | 2.41× | -0.54× | ||
| Q1 25 | 1.21× | 1.44× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | 0.81× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | — | 0.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
